Biogen Inc. (BIIB) News Headlines

▮ More

Date

Headline

9/30/2022 7:21:54 AM Biogen: EMA To Review MAA For BIIB800 - Quick Facts

9/30/2022 7:08:40 AM Biogen: European Medicines Agency Accepts Marketing Authorization Application For BIIB800

9/28/2022 6:53:05 AM Pre-market Movers: SILO, PRTA, BIIB, NXPL, ABOS…

9/27/2022 9:57:17 PM Biogen And Eisai's Lecanemab Slows Progression Of Alzheimer's Disease In Phase 3 Trial

9/26/2022 9:45:33 PM Biogen Agrees To Pay $900 Mln Over Kickback Allegations

7/21/2022 2:33:24 AM ABT Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6%

7/20/2022 8:06:40 AM Biogen Inc. (BIIB) Has Raised Its FY22 Revenue Estimate To $9.9 - $10.1 Bln From $9.7 - $10.0 Bln

7/20/2022 8:06:00 AM Biogen Inc. (BIIB) Has Raised Its FY22 EPS Estimate To 15.25 - 16.75 From 14.25 - 16.00

7/20/2022 7:38:35 AM Biogen Boosts FY22 Outlook As Q2 Results Top Estimates

7/20/2022 7:07:59 AM Biogen Q2 GAAP EPS $7.24; Non-GAAP EPS $5.25

7/20/2022 7:00:10 AM Biogen Q2 22 Earnings Conference Call At 8:00 AM ET

6/3/2022 8:40:22 AM Biogen, Bio-Thera Presents Positive Phase 3 Data For Tocilizumab Biosimilar In Rheumatoid Arthritis

6/3/2022 8:19:47 AM Biogen Present Positive Phase 3 Data For Tocilizumab Biosimilar Candidate In Rheumatoid Arthritis

6/3/2022 5:40:48 AM Ionis: Tofersen Slows Disease Progression In Phase 3 VALOR Study

5/3/2022 7:44:20 AM Biogen Reaffirms FY22 Outlook; Q1 Adj. EPS Misses Estimates

5/3/2022 7:16:47 AM Biogen Q1 GAAP EPS $2.06; Non-GAAP EPS $3.62

5/3/2022 6:00:23 AM Biogen Q1 22 Earnings Conference Call At 8:00 AM ET

5/2/2022 6:36:06 AM Sage Therapeutics, Biogen Begin Rolling Submission Of NDA To US FDA For Zuranolone For Potential Treatment Of MDD

3/30/2022 8:31:30 AM Biogen Submits Final Protocol For Envision Trial Of Aduhelm On Alzheimer's Disease

3/30/2022 7:46:04 AM Biogen Submits Final Protocol For ADUHELM Phase 4 ENVISION Trial To FDA